Eli Lilly
(NYSE) LLY
Eli Lilly Financials at a Glance
Market Cap
$1.05T
Revenue (TTM)
$72.25B
Net Income (TTM)
$25.28B
EPS (TTM)
$27.78
P/E Ratio
40.22
Dividend
$6.46
Beta (Volatility)
0.60 (Low)
Dividend
$6.46
Beta (Volatility)
0.60 (Low)
Price
$1,127.39
Volume
119,261
Open
$1,127.00
Price
$1,127.39
Volume
119,261
Open
$1,127.00
Previous Close
$1,127.39
Daily Range
$1,114.95 - $1,145.23
52-Week Range
$623.78 - $1,182.73
Estimated Earnings Date
Aug 5, 2026
Dividend
$6.46
Beta (Volatility)
0.60 (Low)
Price
$1,127.39
Volume
119,261
Open
$1,127.00
Previous Close
$1,127.39
Daily Range
$1,114.95 - $1,145.23
52-Week Range
$623.78 - $1,182.73
Estimated Earnings Date
Aug 5, 2026
LLY News
LLY: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Eli Lilly
Industry
Pharmaceuticals
Sector
Health CareEmployees
50,000
CEO
David A. Ricks, MBA
Website
www.lilly.comHeadquarters
Indianapolis, IN 46285, US
LLY Financials
Key Financial Metrics (TTM)
Gross Margin
83.51%
Operating Margin
45.87%
Net Income Margin
34.98%
Return on Equity
101.30%
Return on Capital
43.01%
Return on Assets
21.68%
Earnings Yield
2.49%
Dividend Yield
0.58%
Payout Ratio
22.10%
Stock Overview
Market Cap
$1.05T
Shares Outstanding
941.74M
Volume
119.26K
Avg. Volume
3.19M
Financials (TTM)
Gross Profit
$60.33B
Operating Income
$33.14B
EBITDA
$33.46B
Operating Cash Flow
$20.48B
Capital Expenditure
-$6.90B
Free Cash Flow
$13.58B
Cash & ST Invst.
$5.28B
Total Debt
$43.37B
Eli Lilly Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$19.80B
+55.5%
Gross Profit
$16.22B
+54.4%
Gross Margin
81.93%
N/A
Market Cap
$1.05T
N/A
Market Cap/Employee
$22.39M
N/A
Employees
47,000
N/A
Net Income
$7.40B
+168.0%
EBITDA
$9.69B
+132.8%
Quarterly Fundamentals
Total Cash
$5.28B
+64.0%
Total Debt
$43.37B
+12.6%
Accounts Receivable
$21.18B
+51.2%
Inventory
$14.53B
+56.0%
Long Term Debt
$39.37B
+14.1%
Short Term Debt
$4.00B
-0.4%
Return on Assets
21.68%
N/A
Return on Invested Capital
41.45%
N/A
Free Cash Flow
$3.01B
+287.8%
Operating Cash Flow
$5.33B
+220.2%